View printer-friendly version << Back
MEDNAX Announces Acquisition of Anesthesiology Practice in North Carolina

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Mar. 23, 2015-- MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Mosaic Anesthesia & Perioperative Services, P.C., a private physician group practice based in New Bern, N.C. At closing, the practice became part of MEDNAX’s American Anesthesiology division.

Physicians with Mosaic Anesthesia & Perioperative Services have been providing anesthesia services in New Bern and surrounding areas since 1982. The practice employs 15 anesthesiologists that work as part of a care team model including anesthetists at CarolinaEast Medical Center in New Bern and its affiliated ambulatory surgery center, as well as Carteret General Hospital in Morehead City, Columbus Regional Healthcare System in Whiteville and Lenoir Memorial Hospital in Kinston. The practice’s anesthesia services include general anesthesia, neurosurgery (including spine), cardiac, orthopedic, vascular, obstetric, gynecologic and ear, nose and throat (ENT).

“Partnering with MEDNAX presents an opportunity for us to have long-term stability in the marketplace and to be part of a proven business model that will keep us on the forefront of high quality anesthesia care,” said Bill Panza, M.D., who will serve as medical director for the practice. “Not only will MEDNAX provide business leadership, administrative support and access to a nationwide network of our peers, but the company’s longstanding commitment to research, education and clinical quality will support our goals for improved outcomes and patient satisfaction.”

MEDNAX’s American Anesthesiology division consists of more than 2,400 anesthesia providers, including more than 975 physicians and 1,425 anesthetists practicing in 13 states.

This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.


MEDNAX, Inc. is a national medical group comprised of the nation's leading providers of neonatal, anesthesia, maternal-fetal and pediatric physician subspecialty services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a division of MEDNAX, was founded in 1979 and includes neonatal physicians who provide services at more than 370 neonatal intensive care units, and collaborate with affiliated maternal-fetal medicine, pediatric cardiology, pediatric critical care and other physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. American Anesthesiology, a division of MEDNAX, was established in 2007 and includes more than 2,400 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs more than 2,650 physicians in 34 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

Charles Lynch, 954-384-0175, x 5692
Vice President, Strategy and Investor Relations